Mp70-16 Sema3c Drives Cancer Growth and Treatment Resistance via Cognate Ligand-Independent Activation

Journal of Urology - Netherlands
doi 10.1016/j.juro.2018.02.2260
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)